Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 February, 2019 01:39 IST
Zydus Cadila receives USFDA tentative approval for 2 drugs
Source: IRIS | 12 Oct, 2018, 01.12PM
Comments  |  Post Comment

Zydus Cadila has received the tentative approval from the USFDA to market Linagliptin and Metformin HydrochlorideTablets, 2.5 mg/500 mg, 2.5 mg/850 mg and 2.5 mg/ 1,000 mg.



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Zydus Cadila receives final USFDA approvals for 2 drugs - 22-Feb-2019 10:43
Aarti Industries signs USD 125 mn multi-year deal - 20-Feb-2019 10:53
Glenmark to present data on Ryaltris at AAAAI 2019 - 20-Feb-2019 10:48
ABB bags train technologies order worth Rs 2.70 bn - 20-Feb-2019 10:30
Cipla, Wellthy Therapeutics announce partnership to offer digital therapeutics - 19-Feb-2019 10:58
Glenmark Pharma receives ANDA approval for Clobetasol propionate foam - 18-Feb-2019 10:45
L&T Construction secures contract for design and construction of major airport - 18-Feb-2019 10:42
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer